IBDEI07S ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10271,2)
 ;;=^12267
 ;;^UTILITY(U,$J,358.3,10272,0)
 ;;=362.12^^52^594^22
 ;;^UTILITY(U,$J,358.3,10272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10272,1,3,0)
 ;;=3^Coats' Disease
 ;;^UTILITY(U,$J,358.3,10272,1,4,0)
 ;;=4^362.12
 ;;^UTILITY(U,$J,358.3,10272,2)
 ;;=^268612
 ;;^UTILITY(U,$J,358.3,10273,0)
 ;;=362.13^^52^594^88
 ;;^UTILITY(U,$J,358.3,10273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10273,1,3,0)
 ;;=3^Retinal Vascular Changes
 ;;^UTILITY(U,$J,358.3,10273,1,4,0)
 ;;=4^362.13
 ;;^UTILITY(U,$J,358.3,10273,2)
 ;;=^268614
 ;;^UTILITY(U,$J,358.3,10274,0)
 ;;=362.14^^52^594^82
 ;;^UTILITY(U,$J,358.3,10274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10274,1,3,0)
 ;;=3^Retina Microaneurysm NOS
 ;;^UTILITY(U,$J,358.3,10274,1,4,0)
 ;;=4^362.14
 ;;^UTILITY(U,$J,358.3,10274,2)
 ;;=^268615
 ;;^UTILITY(U,$J,358.3,10275,0)
 ;;=362.17^^52^594^52
 ;;^UTILITY(U,$J,358.3,10275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10275,1,3,0)
 ;;=3^Macroaneurysm
 ;;^UTILITY(U,$J,358.3,10275,1,4,0)
 ;;=4^362.17
 ;;^UTILITY(U,$J,358.3,10275,2)
 ;;=^268617
 ;;^UTILITY(U,$J,358.3,10276,0)
 ;;=362.21^^52^594^71
 ;;^UTILITY(U,$J,358.3,10276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10276,1,3,0)
 ;;=3^Prematurity-ROP
 ;;^UTILITY(U,$J,358.3,10276,1,4,0)
 ;;=4^362.21
 ;;^UTILITY(U,$J,358.3,10276,2)
 ;;=^105733
 ;;^UTILITY(U,$J,358.3,10277,0)
 ;;=362.29^^52^594^63
 ;;^UTILITY(U,$J,358.3,10277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10277,1,3,0)
 ;;=3^Nondiabetic PR
 ;;^UTILITY(U,$J,358.3,10277,1,4,0)
 ;;=4^362.29
 ;;^UTILITY(U,$J,358.3,10277,2)
 ;;=^268619
 ;;^UTILITY(U,$J,358.3,10278,0)
 ;;=362.30^^52^594^40
 ;;^UTILITY(U,$J,358.3,10278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10278,1,3,0)
 ;;=3^Hemiretinal Vein Occlusion
 ;;^UTILITY(U,$J,358.3,10278,1,4,0)
 ;;=4^362.30
 ;;^UTILITY(U,$J,358.3,10278,2)
 ;;=^105640
 ;;^UTILITY(U,$J,358.3,10279,0)
 ;;=362.37^^52^594^9
 ;;^UTILITY(U,$J,358.3,10279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10279,1,3,0)
 ;;=3^CRVO-Partial
 ;;^UTILITY(U,$J,358.3,10279,1,4,0)
 ;;=4^362.37
 ;;^UTILITY(U,$J,358.3,10279,2)
 ;;=^268627
 ;;^UTILITY(U,$J,358.3,10280,0)
 ;;=362.50^^52^594^51
 ;;^UTILITY(U,$J,358.3,10280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10280,1,3,0)
 ;;=3^Mac Degen,Senile/Atrophy
 ;;^UTILITY(U,$J,358.3,10280,1,4,0)
 ;;=4^362.50
 ;;^UTILITY(U,$J,358.3,10280,2)
 ;;=^73072
 ;;^UTILITY(U,$J,358.3,10281,0)
 ;;=362.70^^52^594^28
 ;;^UTILITY(U,$J,358.3,10281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10281,1,3,0)
 ;;=3^Degen/Hered Disorder
 ;;^UTILITY(U,$J,358.3,10281,1,4,0)
 ;;=4^362.70
 ;;^UTILITY(U,$J,358.3,10281,2)
 ;;=^268650
 ;;^UTILITY(U,$J,358.3,10282,0)
 ;;=362.74^^52^594^91
 ;;^UTILITY(U,$J,358.3,10282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10282,1,3,0)
 ;;=3^Retinitis Pigmentosa
 ;;^UTILITY(U,$J,358.3,10282,1,4,0)
 ;;=4^362.74
 ;;^UTILITY(U,$J,358.3,10282,2)
 ;;=^105693
 ;;^UTILITY(U,$J,358.3,10283,0)
 ;;=362.75^^52^594^50
 ;;^UTILITY(U,$J,358.3,10283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10283,1,3,0)
 ;;=3^Mac Degen,Juvenile
 ;;^UTILITY(U,$J,358.3,10283,1,4,0)
 ;;=4^362.75
 ;;^UTILITY(U,$J,358.3,10283,2)
 ;;=^268656
 ;;^UTILITY(U,$J,358.3,10284,0)
 ;;=362.76^^52^594^74
 ;;^UTILITY(U,$J,358.3,10284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10284,1,3,0)
 ;;=3^RPE Hypertrophy
 ;;^UTILITY(U,$J,358.3,10284,1,4,0)
 ;;=4^362.76
 ;;^UTILITY(U,$J,358.3,10284,2)
 ;;=^268657
 ;;^UTILITY(U,$J,358.3,10285,0)
 ;;=362.82^^52^594^85
 ;;^UTILITY(U,$J,358.3,10285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10285,1,3,0)
 ;;=3^Retinal Exudates
 ;;^UTILITY(U,$J,358.3,10285,1,4,0)
 ;;=4^362.82
 ;;^UTILITY(U,$J,358.3,10285,2)
 ;;=^268659
 ;;^UTILITY(U,$J,358.3,10286,0)
 ;;=363.12^^52^594^68
 ;;^UTILITY(U,$J,358.3,10286,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10286,1,3,0)
 ;;=3^Periph Disem Choroiditis
 ;;^UTILITY(U,$J,358.3,10286,1,4,0)
 ;;=4^363.12
 ;;^UTILITY(U,$J,358.3,10286,2)
 ;;=^268675
 ;;^UTILITY(U,$J,358.3,10287,0)
 ;;=363.15^^52^594^1
 ;;^UTILITY(U,$J,358.3,10287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10287,1,3,0)
 ;;=3^AMPPE
 ;;^UTILITY(U,$J,358.3,10287,1,4,0)
 ;;=4^363.15
 ;;^UTILITY(U,$J,358.3,10287,2)
 ;;=^268678
 ;;^UTILITY(U,$J,358.3,10288,0)
 ;;=363.33^^52^594^96
 ;;^UTILITY(U,$J,358.3,10288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10288,1,3,0)
 ;;=3^Scars of Post Pole of Chorioret
 ;;^UTILITY(U,$J,358.3,10288,1,4,0)
 ;;=4^363.33
 ;;^UTILITY(U,$J,358.3,10288,2)
 ;;=^268681
 ;;^UTILITY(U,$J,358.3,10289,0)
 ;;=363.41^^52^594^97
 ;;^UTILITY(U,$J,358.3,10289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10289,1,3,0)
 ;;=3^Senile Atrophy of Choroid
 ;;^UTILITY(U,$J,358.3,10289,1,4,0)
 ;;=4^363.41
 ;;^UTILITY(U,$J,358.3,10289,2)
 ;;=^268686
 ;;^UTILITY(U,$J,358.3,10290,0)
 ;;=363.43^^52^594^4
 ;;^UTILITY(U,$J,358.3,10290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10290,1,3,0)
 ;;=3^Angioid Streaks
 ;;^UTILITY(U,$J,358.3,10290,1,4,0)
 ;;=4^363.43
 ;;^UTILITY(U,$J,358.3,10290,2)
 ;;=^7492
 ;;^UTILITY(U,$J,358.3,10291,0)
 ;;=363.50^^52^594^42
 ;;^UTILITY(U,$J,358.3,10291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10291,1,3,0)
 ;;=3^Herediatary Chor Dyst/Atrophy
 ;;^UTILITY(U,$J,358.3,10291,1,4,0)
 ;;=4^363.50
 ;;^UTILITY(U,$J,358.3,10291,2)
 ;;=^268689
 ;;^UTILITY(U,$J,358.3,10292,0)
 ;;=363.55^^52^594^20
 ;;^UTILITY(U,$J,358.3,10292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10292,1,3,0)
 ;;=3^Choroideremia
 ;;^UTILITY(U,$J,358.3,10292,1,4,0)
 ;;=4^363.55
 ;;^UTILITY(U,$J,358.3,10292,2)
 ;;=^23982
 ;;^UTILITY(U,$J,358.3,10293,0)
 ;;=363.57^^52^594^37
 ;;^UTILITY(U,$J,358.3,10293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10293,1,3,0)
 ;;=3^Gyrate Atrophy,Hered
 ;;^UTILITY(U,$J,358.3,10293,1,4,0)
 ;;=4^363.57
 ;;^UTILITY(U,$J,358.3,10293,2)
 ;;=^268695
 ;;^UTILITY(U,$J,358.3,10294,0)
 ;;=363.61^^52^594^16
 ;;^UTILITY(U,$J,358.3,10294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10294,1,3,0)
 ;;=3^Choroidal Hemorrhage
 ;;^UTILITY(U,$J,358.3,10294,1,4,0)
 ;;=4^363.61
 ;;^UTILITY(U,$J,358.3,10294,2)
 ;;=^23966
 ;;^UTILITY(U,$J,358.3,10295,0)
 ;;=363.62^^52^594^17
 ;;^UTILITY(U,$J,358.3,10295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10295,1,3,0)
 ;;=3^Choroidal Hemorrhage,Expulsive
 ;;^UTILITY(U,$J,358.3,10295,1,4,0)
 ;;=4^363.62
 ;;^UTILITY(U,$J,358.3,10295,2)
 ;;=^268697
 ;;^UTILITY(U,$J,358.3,10296,0)
 ;;=363.72^^52^594^41
 ;;^UTILITY(U,$J,358.3,10296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10296,1,3,0)
 ;;=3^Hemorrhagic Choroid Detachment
 ;;^UTILITY(U,$J,358.3,10296,1,4,0)
 ;;=4^363.72
 ;;^UTILITY(U,$J,358.3,10296,2)
 ;;=^268700
 ;;^UTILITY(U,$J,358.3,10297,0)
 ;;=363.8^^52^594^36
 ;;^UTILITY(U,$J,358.3,10297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10297,1,3,0)
 ;;=3^Folds,Oth Retinal D/O
 ;;^UTILITY(U,$J,358.3,10297,1,4,0)
 ;;=4^363.8
 ;;^UTILITY(U,$J,358.3,10297,2)
 ;;=^268701
 ;;^UTILITY(U,$J,358.3,10298,0)
 ;;=379.25^^52^594^60
 ;;^UTILITY(U,$J,358.3,10298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10298,1,3,0)
 ;;=3^Membranes and Strands
 ;;^UTILITY(U,$J,358.3,10298,1,4,0)
 ;;=4^379.25
 ;;^UTILITY(U,$J,358.3,10298,2)
 ;;=^269311
 ;;^UTILITY(U,$J,358.3,10299,0)
 ;;=743.49^^52^594^24
 ;;^UTILITY(U,$J,358.3,10299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10299,1,3,0)
 ;;=3^Congenital Coloboma,Oth
 ;;^UTILITY(U,$J,358.3,10299,1,4,0)
 ;;=4^743.49
 ;;^UTILITY(U,$J,358.3,10299,2)
 ;;=^87419
 ;;^UTILITY(U,$J,358.3,10300,0)
 ;;=743.51^^52^594^67
 ;;^UTILITY(U,$J,358.3,10300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10300,1,3,0)
 ;;=3^PHPV
 ;;^UTILITY(U,$J,358.3,10300,1,4,0)
 ;;=4^743.51
 ;;^UTILITY(U,$J,358.3,10300,2)
 ;;=^272828
 ;;^UTILITY(U,$J,358.3,10301,0)
 ;;=743.59^^52^594^70
 ;;^UTILITY(U,$J,358.3,10301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10301,1,3,0)
 ;;=3^Posterior Seg Anomaly Congenital
 ;;^UTILITY(U,$J,358.3,10301,1,4,0)
 ;;=4^743.59
 ;;^UTILITY(U,$J,358.3,10301,2)
 ;;=^272839
 ;;^UTILITY(U,$J,358.3,10302,0)
 ;;=757.33^^52^594^23
 ;;^UTILITY(U,$J,358.3,10302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10302,1,3,0)
 ;;=3^Cong Pigment Anom of Skin
 ;;^UTILITY(U,$J,358.3,10302,1,4,0)
 ;;=4^757.33
 ;;^UTILITY(U,$J,358.3,10302,2)
 ;;=^27472
 ;;^UTILITY(U,$J,358.3,10303,0)
 ;;=909.2^^52^594^48
 ;;^UTILITY(U,$J,358.3,10303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10303,1,3,0)
 ;;=3^Late Effect of Radiation Retinopathy
 ;;^UTILITY(U,$J,358.3,10303,1,4,0)
 ;;=4^909.2
 ;;^UTILITY(U,$J,358.3,10303,2)
 ;;=^275257
 ;;^UTILITY(U,$J,358.3,10304,0)
 ;;=377.41^^52^595^91
 ;;^UTILITY(U,$J,358.3,10304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10304,1,3,0)
 ;;=3^Optic Neuropathy, Ischemic
 ;;^UTILITY(U,$J,358.3,10304,1,4,0)
 ;;=4^377.41
 ;;^UTILITY(U,$J,358.3,10304,2)
 ;;=Optic Neuropathy, Ischemic^269231
 ;;^UTILITY(U,$J,358.3,10305,0)
 ;;=377.21^^52^595^33
 ;;^UTILITY(U,$J,358.3,10305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10305,1,3,0)
 ;;=3^Drusen (ONH)
 ;;^UTILITY(U,$J,358.3,10305,1,4,0)
 ;;=4^377.21
 ;;^UTILITY(U,$J,358.3,10305,2)
 ;;=^269221
 ;;^UTILITY(U,$J,358.3,10306,0)
 ;;=377.10^^52^595^79
 ;;^UTILITY(U,$J,358.3,10306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10306,1,3,0)
 ;;=3^Optic Atrophy
 ;;^UTILITY(U,$J,358.3,10306,1,4,0)
 ;;=4^377.10
 ;;^UTILITY(U,$J,358.3,10306,2)
 ;;=^85926
 ;;^UTILITY(U,$J,358.3,10307,0)
 ;;=377.30^^52^595^90
 ;;^UTILITY(U,$J,358.3,10307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10307,1,3,0)
 ;;=3^Optic Neuritis,Unspec
 ;;^UTILITY(U,$J,358.3,10307,1,4,0)
 ;;=4^377.30
 ;;^UTILITY(U,$J,358.3,10307,2)
 ;;=^86002
 ;;^UTILITY(U,$J,358.3,10308,0)
 ;;=377.01^^52^595^96
 ;;^UTILITY(U,$J,358.3,10308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10308,1,3,0)
 ;;=3^Papilledema
 ;;^UTILITY(U,$J,358.3,10308,1,4,0)
 ;;=4^377.01
 ;;^UTILITY(U,$J,358.3,10308,2)
 ;;=Papilledema Associated with Increased Intracranial Pressure^269212
